All In Biotech

Drug Trial Radar · NCT07373639

A Long-term Follow-up Study in Patients Who Received BEAM-101

A Long-term Follow-up Study in Patients With Hemoglobinopathy Who Received Autologous CD34+ Edited Hematopoietic Stem Cells

Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Dec 15, 2025

Primary completion

Feb 12, 2043

Study completion Feb 12, 2043

Sponsor

Lead sponsor
Beam Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Jan 28, 2026

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 14 years, up to 37 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed for 13 years (a total of 15 years after receiving BEAM-101).

Conditions

  • Hemoglobinopathy
  • Sickle Cell Disease

Interventions

  • Long-Term Follow-up Study of patients who received BEAM-101Drug

    This is a Long-Term Follow-up Study of patients who received a single dose of BEAM-101 administered by IV following myeloablative conditioning with busulfan

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-Term Safety Monitoring and Mortality AssessmentTime frame: Up to 13 years

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Not yet recruiting

  • Phoenix Children's Hospital

    Phoenix, Arizona · Not yet recruiting

  • Mayo Clinic Florida

    Jacksonville, Florida · Not yet recruiting

  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston

    Atlanta, Georgia · Not yet recruiting

  • Boston Children's Hospital

    Boston, Massachusetts · Recruiting

  • Henry Ford Cancer Center

    Detroit, Michigan · Not yet recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Not yet recruiting

  • Washington University School of Medicine in St. Louis

    St Louis, Missouri · Not yet recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Not yet recruiting

  • Columbia University Irving Medical Center

    New York, New York · Not yet recruiting

  • University Hospitals Clevland Medical Center

    Cleveland, Ohio · Not yet recruiting

  • The Clevland Clinic Foundation

    Cleveland, Ohio · Not yet recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Not yet recruiting

  • Medical University of South Carolina

    Charleston, South Carolina · Not yet recruiting

  • St. Jude Children's Research Hospital

    Memphis, Tennessee · Not yet recruiting

  • The Children's Hospital at TriStar Centennial

    Nashville, Tennessee · Not yet recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.